SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation

RegulatorypositiveMerlin CP-GEPPositive

AI Analysis

Summary

SkylineDx's Merlin CP-GEP has been granted FDA Breakthrough Device Designation. This designation expedites the development and review of devices that demonstrate potential to provide more effective treatment for life-threatening or irreversibly debilitating conditions.

Outcome Details

Granted FDA Breakthrough Device Designation

Importance:7/10

Sentiment:

0.80

FDAbreakthrough_designationmedical_deviceregulatory

Related Companies

$CSTL

Read the original article

Published by yahoo_finance on July 1, 2026 9:41 PM

Read Original